The impact of C4d and microvascular inflammation before we knew them

Clinical Transplantation

Volumn 27, Issue 3, 2013, Pages 388-396

  Verghese, Priya ^a   Dunn, Ty ^a   Najafian, Behzad ^a   Kim, Youngki ^a   Matas, Arthur ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Antibody mediated; C4d; Donor specific antibody; Kidney transplant; Microvascular inflammation; Rejection; Transplant pathology

Indexed keywords

AZATHIOPRINE; CD31 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; MYCOPHENOLIC ACID; TACROLIMUS; THYMOCYTE ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLARITIS; CHILD; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULITIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR INFLAMMATION; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; ALLOTRANSPLANTATION; COMPLICATION; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; IMMUNOLOGY; INFLAMMATION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL RATE; VASCULAR DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; COMPLEMENT C4B; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES; YOUNG ADULT;

EID: 84878666578     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12111     Document Type: Article

References (22)

1. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003: 3: 708.
2. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
3. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008: 8: 753.
4. Loupy A, Hill GS, Suberbielle C et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011: 11: 56.
5. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009: 9: 2520.
6. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010: 15: 42.
7. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009: 9: 2312.
8. Mengel M, Sis B, Haas M et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012: 12: 563.
9. Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002: 13: 1091.
10. Bohmig G, Regele H. Diagnosis and treatment of antibody-mediated kidney allograft rejection. Transpl Int 2003: 16: 773.
11. Haririan A, Kiangkitiwan B, Kukuruga D et al. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009: 9: 2758.
12. Lorenz M, Regele H, Schillinger M et al. Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation 2004: 78: 447.
13. Gibson IW, Gwinner W, Bröcker V et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008: 8: 819.
14. Olsen S, Spencer E, Cockfield S, Marcussen N, Solez K. Endocapillary glomerulitis in the renal allograft. Transplantation 1995: 59: 1421.
15. Batal I, Lunz JG 3rd, Aggarwal N, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010: 10: 2442.
16. Dickenmann M, Steiger J, Descoeudres B, Mihatsch M, Nickeleit V. The fate of C4d positive kidney allografts lacking histological signs of acute rejection. Clin Nephrol 2006: 65: 173.
17. Haas M, Rahman MH, Racusen LC et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006: 6: 1829.
18. Haas M. The significance of C4d staining with minimal histologic abnormalities. Curr Opin Organ Transplant 2010: 15: 21.
19. Hirohashi T, Chase CM, Della Pelle P et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012: 12: 313.
20. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009: 9: 2561.
21. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005: 68: 1866.
22. Messias NC, Eustace JA, Zachary AA, Tucker PC, Charney D, Racusen LC. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001: 72: 655.